Avidian Wealth Enterprises’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Buy
33,988
+3,234
+11% +$379K 0.12% 122
2026
Q1
$3.7M Buy
30,754
+14,925
+94% +$1.72M 0.12% 123
2025
Q4
$1.67M Buy
15,829
+411
+3% +$38.6K 0.06% 165
2025
Q3
$1.29M Buy
15,418
+1,699
+12% +$140K 0.05% 184
2025
Q2
$1.09M Sell
13,719
-3,039
-18% -$242K 0.04% 194
2025
Q1
$1.5M Sell
16,758
-272
-2% -$25.4K 0.07% 154
2024
Q4
$1.69M Sell
17,030
-670
-4% -$69.1K 0.08% 137
2024
Q3
$2.01M Buy
17,700
+770
+5% +$91.5K 0.09% 116
2024
Q2
$2.1M Buy
16,930
+1,727
+11% +$222K 0.09% 111
2024
Q1
$2.01M Buy
15,203
+1,633
+12% +$201K 0.1% 111
2023
Q4
$1.48M Buy
13,570
+2,258
+20% +$234K 0.09% 130
2023
Q3
$1.16M Sell
11,312
-881
-7% -$95K 0.08% 147
2023
Q2
$1.41M Sell
12,193
-11,462
-48% -$1.3M 0.09% 145
2023
Q1
$2.52M Buy
23,655
+2,165
+10% +$234K 0.14% 124
2022
Q4
$2.38M Buy
21,490
+2,299
+12% +$235K 0.16% 110
2022
Q3
$1.65M Buy
19,191
+85
+0.4% +$7.59K 0.12% 116
2022
Q2
$1.74M Buy
19,106
+1,506
+9% +$134K 0.12% 122
2022
Q1
$1.44M Buy
17,600
+80
+0.5% +$6.31K 0.09% 149
2021
Q4
$1.34M Buy
17,520
+3,353
+24% +$267K 0.08% 155
2021
Q3
$1.06M Buy
14,167
+2,282
+19% +$174K 0.08% 129
2021
Q2
$924K Buy
11,885
+2,446
+26% +$182K 0.07% 140
2021
Q1
$694K Buy
9,439
+1,005
+12% +$74.1K 0.06% 162
2020
Q4
$658K Sell
8,434
-421
-5% -$32.2K 0.06% 149
2020
Q3
$701K Sell
8,855
-2,151
-20% -$168K 0.08% 123
2020
Q2
$812K Sell
11,006
-2,835
-20% -$213K 0.11% 101
2020
Q1
$1.02M Buy
13,841
+483
+4% +$38K 0.16% 70
2019
Q4
$1.16M Sell
13,358
-48
-0.4% -$3.94K 0.16% 60
2019
Q3
$1.08M Sell
13,406
-2,697
-17% -$216K 0.18% 53
2019
Q2
$1.29M Buy
+16,103
New +$1.23M 0.3% 32

Other funds holding MRK

Avidian Wealth Enterprises's MRK Position: Q2 2026 in Review

Avidian Wealth Enterprises increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $379K and bringing the position to 33,988 shares worth $4.37M. The position accounts for 0.12% of the portfolio, ranked #122.

Avidian Wealth Enterprises first reported a position in MRK in Q2 2019 and has held it in 29 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Avidian Wealth Enterprises held 33,988 shares of Merck worth $4.37M as of Q2 2026.
  • Avidian Wealth Enterprises bought 3,234 Merck shares in Q2 2026, an estimated $379K.
  • Merck made up 0.12% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #122 holding.
  • Avidian Wealth Enterprises first reported a position in Merck in Q2 2019 and has held it in 29 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.